Correlation Between Prometheus Biosciences and Blueprint Medicines
Can any of the company-specific risk be diversified away by investing in both Prometheus Biosciences and Blueprint Medicines at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Prometheus Biosciences and Blueprint Medicines into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Prometheus Biosciences and Blueprint Medicines Corp, you can compare the effects of market volatilities on Prometheus Biosciences and Blueprint Medicines and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Prometheus Biosciences with a short position of Blueprint Medicines. Check out your portfolio center. Please also check ongoing floating volatility patterns of Prometheus Biosciences and Blueprint Medicines.
Diversification Opportunities for Prometheus Biosciences and Blueprint Medicines
0.06 | Correlation Coefficient |
Significant diversification
The 3 months correlation between Prometheus and Blueprint is 0.06. Overlapping area represents the amount of risk that can be diversified away by holding Prometheus Biosciences and Blueprint Medicines Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Blueprint Medicines Corp and Prometheus Biosciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Prometheus Biosciences are associated (or correlated) with Blueprint Medicines. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Blueprint Medicines Corp has no effect on the direction of Prometheus Biosciences i.e., Prometheus Biosciences and Blueprint Medicines go up and down completely randomly.
Pair Corralation between Prometheus Biosciences and Blueprint Medicines
If you would invest 9,275 in Blueprint Medicines Corp on August 28, 2024 and sell it today you would earn a total of 112.00 from holding Blueprint Medicines Corp or generate 1.21% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 1.59% |
| Values | Daily Returns |
Prometheus Biosciences vs. Blueprint Medicines Corp
Performance |
| Timeline |
| Prometheus Biosciences |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
| Blueprint Medicines Corp |
Prometheus Biosciences and Blueprint Medicines Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Prometheus Biosciences and Blueprint Medicines
The main advantage of trading using opposite Prometheus Biosciences and Blueprint Medicines positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Prometheus Biosciences position performs unexpectedly, Blueprint Medicines can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Blueprint Medicines will offset losses from the drop in Blueprint Medicines' long position.| Prometheus Biosciences vs. Apellis Pharmaceuticals | Prometheus Biosciences vs. Akero Therapeutics | Prometheus Biosciences vs. Immunovant | Prometheus Biosciences vs. Madrigal Pharmaceuticals |
| Blueprint Medicines vs. Eliem Therapeutics | Blueprint Medicines vs. HCW Biologics | Blueprint Medicines vs. Scpharmaceuticals | Blueprint Medicines vs. Milestone Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Aroon Oscillator module to analyze current equity momentum using Aroon Oscillator and other momentum ratios.
Other Complementary Tools
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets |